These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 15773501

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Characteristic of clinical strains of gram-negative obligate anaerobes].
    Kadzielska J, Kierzkowska M, Sawicka-Grzelak A, Rokosz A, Łuczak M.
    Med Dosw Mikrobiol; 2007; 59(4):351-7. PubMed ID: 18416127
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Susceptibility to antimicrobial drugs of enterotoxin producing strains of Bacteroides fragilis isolated from different countries].
    Obuch-Woszczatyński P, Rokosz A, Sawicka-Grzelak A, Pituch H, Meisel-Mikołajczyk F, Łuczak M.
    Med Dosw Mikrobiol; 2002; 54(3):253-8. PubMed ID: 12632660
    [Abstract] [Full Text] [Related]

  • 5. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR, Spangler SK, Appelbaum PC.
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
    Treviño M, Areses P, Peñalver MD, Cortizo S, Pardo F, del Molino ML, García-Riestra C, Hernández M, Llovo J, Regueiro BJ.
    Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
    Toprak NU, Yağci A, Celik C, Cakici O, Söyletir G.
    Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
    [Abstract] [Full Text] [Related]

  • 9. [Antibiotic susceptibility and occurrence of ESBL, IBL and MBL in Pseudomonas aeruginosa strains].
    Wolska K, Jakubczak A, Soszyńska A.
    Med Dosw Mikrobiol; 2008 Apr; 60(2):111-9. PubMed ID: 18819447
    [Abstract] [Full Text] [Related]

  • 10. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R, Petzold S, Fille M, Rodloff AC.
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
    García-Rodríguez JA, García Sánchez JE, Trujillano I, Muñoz-Bellido JL.
    J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Occurrence of beta-lactamase type ESBL in rods of the Serratia species].
    Ulatowska B, Czajkowski H, Gospodarek E, Mikucka A.
    Med Dosw Mikrobiol; 2000 Feb; 52(1):17-24. PubMed ID: 11107776
    [Abstract] [Full Text] [Related]

  • 15. [Identification and susceptibility to antimicrobial agents of strictly anaerobic bacteria isolated from hospitalized patients].
    Kot K, Rokosz A, Sawicka-Grzelak A, łuczak M.
    Med Dosw Mikrobiol; 2002 Feb; 54(3):233-41. PubMed ID: 12632658
    [Abstract] [Full Text] [Related]

  • 16. [Use of new methods for detection of beta-lactamases with extended-spectrum substrates (ESBLs)].
    Rokosz A, Sawicka-Grzelak A, Mészáros J, łuczak M.
    Med Dosw Mikrobiol; 2002 Feb; 54(3):225-31. PubMed ID: 12632657
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L, Castello L, Di Martino A, Greco G, Legaria MC, Litterio M, Predari SC, Rollet R, Rossetti A, Carloni G, Sarchi MI, Bianchini H.
    Rev Argent Microbiol; 2007 Feb; 39(3):156-60. PubMed ID: 17987852
    [Abstract] [Full Text] [Related]

  • 18. [Detection of beta-lactamases in the Bacteroides fragilis group].
    Martin C, Dubreuil L, Sedallian A, Romond C.
    Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
    [Abstract] [Full Text] [Related]

  • 19. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
    Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Golan Y, Goldstein EJ, Finegold SM, Harrell LJ, Hecht DW, Jenkins SG, Pierson C, Venezia R, Yu V, Rihs J, Gorbach SL.
    Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA, Castillo AM, Liébana J, Marín A, Alados JC, Piédrola G.
    J Hyg Epidemiol Microbiol Immunol; 1991 May; 35(2):189-97. PubMed ID: 1940333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.